IL1A and cancer: They suppress innate and adaptive immune systems, including suppressing of T-cells through prostaglandin E2, CXCL9, CXCL10, and CXCL11, and nitric oxide synthase [156] in response to cancer cell-secreted TNFα, IFNγ, and IL-1 [46].